Health apps

Number of report

Ask the expert

(we accept only company emails)

Digital health is a dynamic field with a significant amount of innovation. Digital health technologies include solutions for tele-consultation, remote monitoring, connected devices, digital platforms and health apps. 

While health apps are becoming of high interest to patients, healthcare providers and payers, it takes time for reimbursement systems to adjust and introduce a payment mechanism for health apps. 

Reimbursement is one of the key barriers for the adoption and wide dissemination of health apps. 

In this report, the leading European Med Tech consultancy MTRC summarized information about current and future administrative and reimbursement landscape for health apps in the countries with the most advanced payment systems for E-health in Europe. 

A syndicated 105-page report includes information on the current administrative framework for health apps, current reimbursement framework, examples of reimbursed apps, the role of health technology assessment, upcoming changes in the reimbursement systems. 

Reimbursement information is provided for the following geographies:

  • Belgium
  • England
  • France
  • Germany
  • The Netherlands

See more information and obtain sample pages here

Table of content is not available at the moment. Report is still ongoing.


Oct 2021

The Scottish Health Technologies Group (SHTG) is a national health technology assessment (HTA) agency providing advice to NHSScotland on the use of new and existing health technologies, likely to have a significant impact on healthcare. In the third quarter of 2021, SHTG published only one report in relation to HeartFlow fractional flow reserve computerized tomography (FFRCT). Currently, the SHTG is working on assessments of technologies in the field of diabetes, digital health, surgical procedures, and other topics.

Read more


Oct 2021

On September 20, 2021, Swedish Medical Technologies Product (MTP) Council announced ongoing horizon scanning for medical technology products used in obstructive lung diseases within the Orderly introduction framework. The Dental and Pharmaceutical Benefits Agency (TLV) initiated a theme survey, accepting suggestions until October 15, 2021.

Read more


Oct 2021

In September 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis, transapical transcatheter mitral valve-in-ring (TMVIR) after failed annuloplasty for mitral valve repair, and lateral elbow resurfacing for arthritis), and two new Medtech Innovation Briefings (Carnation Ambulatory Monitor, OrganOx metra for liver transplant). Also, one clinical guideline was updated.

Read more


Oct 2021

On September 10, 2021, it was announced that the Government of Spain had increased the budget allocated to the Spanish Network of Agencies for the Evaluation of Health Technologies and Benefits (RedETS) by 48.2% (compared to last year) for the development of the annual work plan. In total, the 2021 budget for the evaluation of health technologies in the National Health System amounts to €6,149,510. As a consequence of the budget increase, the RedETS 2021 Work Plan has included three new lines of evaluation.

Read more


Sep 2021

In August 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (magnetic resonance therapy for knee osteoarthritis, laparoscopic removal of uterine fibroids with power morcellation, hysteroscopic mechanical tissue removal for uterine fibroids), and six new Medtech Innovation Briefings (PLASMA system with button electrode, Immunoscore, MMprofiler, Patient Status Engine, lung texture analysis, Colli-Pee). Also, five clinical guidelines were published.

Read more
(we accept only company emails)